
|Videos|June 1, 2023
Efficacy and Safety of Combination Treatments for BCC
Experts in dermatology discuss the efficacy and safety combining hedgehog pathway inhibitors and immunotherapy as treatment for patients with basal cell carcinoma.
Advertisement
Episodes in this series

Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Kyowa Kirin Takes Full Control of Rocatinlimab Program
2
Dermatology Times January 2026 Recap
3
Galderma Prioritizes Menopause-Related Skin Health with New Data at IMCAS 2026
4
Phase 2 TYK2 Inhibition Shows Promise in AD
5




















